RespireRx Pharmaceuticals Inc (fka RSPI)

[money4retirement]

yes, it certainly would be, and it's a good possibility, as you point out, based on the other deals being made.

what seems low to me is the $8 pps post partnership deal that's been estimated as of late, if (we all know what the "if" is). and while i would be happy to get to $8 because that would mean the "if" finally happened (and $8 is a lot better than $2.65). we were at 6$ pre-fda approval a little over a year ago, with fda approval and with the extensive additional testing on cx717 (as someone stated, and i agree, that makes the chances of a problems arising much less and adds value), those two things i'm guessing will get us to a pps of $8. then a good partnership in light of other deals, i'm guessing will get us to a pps of $12.

if i remember correctly, i think "neuro" pre fda hold had a $12 price target on cor. i don't see why the current pps estimate should be less "if" the fda gives cor the green light..

of course this comes from someone who has 100% invested in COR.
i hope we don't have to wait much longer for the fda decision.

good luck to cor shareholders.

fred